What is Medisafe?
Founded in 2012 and headquartered in Boston, Massachusetts, Medisafe provides a comprehensive medication management platform designed to enhance patient adherence through personalized content, digital resources, and clinical interventions. By fostering seamless collaboration between patients, caregivers, and healthcare professionals, the platform serves as a critical infrastructure for chronic disease management. Medisafe distinguishes itself through a robust, HIPAA and GDPR-compliant architecture, ensuring data security while delivering actionable insights that improve health outcomes. Its market position is defined by its ability to integrate into the broader healthcare ecosystem, providing value-added reports that assist clinicians in monitoring patient progress effectively.
How much funding has Medisafe raised?
Medisafe has raised a total of $51.6M across 5 funding rounds:
Angel/Seed
$1M
Series A
$6M
Series B
$14.5M
Debt
$150K
Series C
$30M
Angel/Seed (2013): $1M with participation from lool ventures and TriVentures
Series A (2015): $6M led by lool ventures, Pitango Venture Capital, 7wire ventures, and TriVentures
Series B (2017): $14.5M supported by Pitango Venture Capital, Qualcomm Ventures, TriVentures, lool ventures, Octopus Ventures, M Ventures, and 7wire ventures
Debt (2020): $150K featuring PPP
Series C (2021): $30M backed by Consensus Business Group, Leumi Partners, Octopus Ventures, Sanofi Ventures, Pitango HealthTech, Triventures, M-Ventures, ALIVE Israel HealthTech Fund, Menorah Mivtachim, Qualcomm Ventures, OurCrowd, 7wireVentures, and lool Ventures
Key Investors in Medisafe
Pitango Venture Capital
Pitango is a venture capital firm that partners with visionary entrepreneurs and groundbreaking companies, supporting them from stealth mode to maturity.
Qualcomm Ventures
Qualcomm Incorporated is a global technology company that develops advanced semiconductor technologies, wireless communication solutions, and intelligent computing platforms.
TriVentures
Triventures is a global venture capital fund that invests in early-stage companies with innovative breakthroughs in healthcare and other industries.
What's next for Medisafe?
Following its latest major strategic investment, Medisafe is well-positioned to scale its enterprise operations and expand its footprint in the global healthtech market. The company is expected to leverage this capital to enhance its data-driven intervention capabilities and deepen its integration with existing healthcare provider networks. As the industry shifts toward value-based care, Medisafe's focus on patient-centric technology will likely remain a core driver of its long-term growth strategy. Future developments will likely prioritize the expansion of its caregiver tools and the refinement of its predictive analytics engine to further reduce medication non-adherence on a global scale.
See full Medisafe company page
